These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 3891412)

  • 21. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
    Binder J; Henneking K
    Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evolution of the principles of the treatment in melanoma of the skin (based on the records of the P. A. Hertzen Oncologic Research Institute in Moscow)].
    Demidov VP; Ostrovtsev LD; Zhukov VM; Fomin AIu
    Sov Med; 1989; (3):60-5. PubMed ID: 2660307
    [No Abstract]   [Full Text] [Related]  

  • 25. Current and planned multicenter trials for patients with primary or metastatic melanoma.
    Sondak VK; Han D; Deneve J; Kudchadkar R
    J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy for cutaneous melanoma.
    Nathan FE; Mastrangelo MJ
    Semin Oncol; 1995 Dec; 22(6):647-61. PubMed ID: 8539640
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adjuvant therapy of surgically removed stage I melanoma].
    Weil M; Borel C; Rixe O; Antoine E; Auclerc G; Banzet P; Khayat D
    Ann Dermatol Venereol; 1995; 122(5):315-8. PubMed ID: 8572473
    [No Abstract]   [Full Text] [Related]  

  • 28. [The present status of the multidisciplinary treatment of malignant melanoma].
    Ishihara K; Hayasaka K; Ikegawa S; Kageshita T
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1073-8. PubMed ID: 4057571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of adjuvant therapy with the preparation Poly-a Poly-u in patients with malignant melanoma during a 10-year observation].
    Pawlicki M; Jońca M; Krzemieniecki K; Zuchowska-Vogelgesang B
    Wiad Lek; 1993 Dec; 46(23-24):912-4. PubMed ID: 7900387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug clinics. How I treat cutaneous melanoma].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 1998 Jan; 53(1):4-6. PubMed ID: 9555173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of melanoma of the skin with regional metastases].
    Bazhenova AP; Romanova OA; Papliian NP
    Khirurgiia (Mosk); 1983 Nov; (11):18-22. PubMed ID: 6664002
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.
    Möller MG; Salwa S; Soden DM; O'Sullivan GC
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1611-30. PubMed ID: 19895245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma.
    Bernhardt MB; Hicks MJ; Pappo AS
    Pediatr Blood Cancer; 2009 Dec; 53(7):1346-8. PubMed ID: 19731326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of malignant melanoblastoma of the skin].
    Oldhoff J; Koudstaal J; van Goch JJ
    Ned Tijdschr Geneeskd; 1968 Aug; 112(32):1433-8. PubMed ID: 5679594
    [No Abstract]   [Full Text] [Related]  

  • 35. [Malignant melanoma and its treatment].
    Luther U; Dichmann S; Norgauer J
    Med Monatsschr Pharm; 2001 Nov; 24(11):356-61. PubMed ID: 11727297
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of malignant melanoma revisited.
    Lejeune FJ
    Acta Chir Belg; 1997 Oct; 97(5):209-14. PubMed ID: 9394960
    [No Abstract]   [Full Text] [Related]  

  • 37. [New radiological-surgical concepts in the primary treatment of malignant melanomas].
    Scherer E; Magnus L; Makoski HB
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Feb; 118(2):174-8. PubMed ID: 4348523
    [No Abstract]   [Full Text] [Related]  

  • 38. Recurrent cutaneous melanoma: a surgical perspective.
    Yeung RS
    Semin Oncol; 1993 Oct; 20(5):400-18. PubMed ID: 8211191
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
    Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE
    Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572
    [No Abstract]   [Full Text] [Related]  

  • 40. Is prophylactic popliteal node dissection necessary in malignant melanoma of the foot?
    Abu-Eshy S
    East Afr Med J; 1995 May; 72(5):338. PubMed ID: 7555894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.